{"cdcTestId":"2018-0013","testcaseName":"Zoster: Dose #1 of RZV administered 8 weeks after previous dose of ZVL","vaccineGroup":"ZOSTER","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1971-08-24T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"SHINGRIX","cvx":"187","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"2023-06-15T00:00:00"},"doses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"SHINGRIX","cvx":"187","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-04-11T20:00:00","dateUpdated":"2022-09-27T08:47:50.426","generalDescription":"This test case describes when an adult patient is administered the first dose of RZV 8 weeks after a previous dose of ZVL, that the dose is valid.","changedInVersion":"4.27","reasonForChange":"v 4.27 Updated Forecast minimum interval from 8 weeks to 4 weeks, to align with ACIP recommendations."}